Neogen(NEOG) Prnewswire·2025-01-21 13:45Core Insights - Neogen Corporation has launched Igenity BCHF, a genomic test aimed at improving bovine heart health standards [1][3] - Bovine Congestive Heart Failure (BCHF) poses a significant threat to cattle health and productivity, and the new test offers a method for better selection based on genetic predisposition [2][3] Industry Impact - Igenity BCHF assesses an animal's genetic risk for BCHF on a scale of 1 to 10, where each decrease in score correlates with an approximately 3.5% lower expected incidence rate for the disease [2] - The test allows producers to manage BCHF risk more effectively, potentially reducing mortality rates in feedlot settings and minimizing economic losses associated with the disease [3][4] Technological Advancement - Igenity BCHF is the first genomic test of its kind, providing insights into the genetic factors contributing to BCHF in cattle [4] - The test results can indicate the likelihood of disease development and the risk that animals may pass on to their offspring [3] Company Overview - Neogen Corporation is dedicated to enhancing global food security through advancements in human and animal well-being, with a presence in over 140 countries [5] - The company focuses on delivering optimized products and technology across various markets, including Food Safety, Livestock, and Pet Health & Wellness [5]